Category: Uncategorized

  • Chronic Back Pain Shrinks ‘Thinking Parts’ of Brain

    November 23, 2004 Chronic Back Pain Shrinks ‘Thinking Parts’ of Brain CHICAGO—Chronic back pain, a condition afflicting many Americans, shrinks the brain by as much as 11 percent—equivalent to the amount of gray matter lost in 10 to 20 years of normal aging, a Northwestern University research study found. Loss in brain density is related[…]

  • Robert Bazell to Give Feinberg Lecture

    November 3, 2004 Robert Bazell to Give Feinberg Lecture CHICAGO—Robert Bazell, NBC News’ chief health and science correspondent, will be the lecturer at the 9th Annual Frances Feinberg Memorial Lecture on November 15 at the Feinberg Pavilion Conference Center, third floor, 251 East Huron Street. There will be a reception at 4:30 p.m., followed by[…]

  • Cruise Ships: Alternative for Elderly Living?

    November 9, 2004 Cruise Ships: Alternative for Elderly Living? CHICAGO—Living on a cruise ship is a feasible and cost-effective option to assisted living facilities, and the services offered on a cruise ship parallel—even surpass—what is provided in senior care facilities, according to a study in the November issue of the Journal of the American Geriatric[…]

  • Bazell Speaks at Feinberg Lecture

    Feinberg Lecture Features NBC’s Robert Bazell This year’s shortage of the flu vaccine has once again highlighted a potential public health threat that shouldn’t be taken lightly, according to Robert Bazell, chief health and science correspondent for NBC News and a regular contributor to NBC Nightly News, Today, and Dateline NBC. Bazell spoke at the[…]

  • Scientist Receives $3.5 Million to Study Genetics of ALS

    Scientist Receives $3.5 Million to Study Genetics of ALS Teepu Siddique, MD, Abbott Labs Duane and Susan Burnham Research Professor at the Feinberg School, has received a $3.5 million grant from the National Institute of Neurological Disorders and Stroke to study the genetics of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. ALS[…]

  • System Helps Curb Severe Anemia

    October 5, 2004 System Helps Curb Severe Anemia CHICAGO—Cooperation among international adverse event reporting agencies has led to an 83 percent decline in a rare, potentially life-threatening form of anemia associated with recombinant human erythropoietin (epoetin), a widely used product for anemia that occurs among cancer patients or persons undergoing dialysis. Epoetin is the most[…]

  • Aneurysm Study Uses Gene Bank Samples

    September 28, 2004 Aneurysm Study Uses Gene Bank SamplesCHICAGO—In a major milestone in genetic research at Northwestern University, a study on the possible genetic causes of abdominal aortic aneurysms will be the first to use samples from NUgene, the University’s gene banking project. William Pearce, MD, professor of surgery and chief of vascular surgery at[…]

  • Arthritis Costs Are Double That of Other Patients

    Arthritis Costs Are Double That of Other Patients By Elizabeth Crown Medical care expenditures for those with arthritis are at least double the amount spent by those without arthritis, according to research presented at the American College of Rheumatology Annual Scientific Meeting in San Antonio, Texas. Researchers from Northwestern University used results from the 1999–2000[…]

  • Study Looks at Drug to Treat Brain Cancer

    October 6, 2004 Study Looks at Drug to Treat Brain Cancer CHICAGO—A Northwestern University cancer researcher is conducting a study that will compare the effects of whole brain radiation therapy with supplemental oxygen without or with EfaproxynTM (efaproxiral), an experimental radiation sensitizer, in participants with brain cancer originating from metastatic breast cancer. Efaproxiral may improve[…]

  • Grant to Advance Technologies for Diabetes

    October 21, 2004 Grant to Advance Technologies for Diabetes By Elizabeth Crown CHICAGO—Northwestern University has received a major grant from the Juvenile Diabetes Research Foundation (JDRF) to advance technologies in the field of islet cell replacement for the treatment of type 1 diabetes. Principal investigator on the $1.5 million JDRF program project is Dixon B.[…]